High-Resolution CT Quantification of Bronchiectasis

High-Resolution CT Quantification of Bronchiectasis



High-Resolution CT Quantification of Bronchiectasis

Gaik C. Ooi, MRCP, FRCR ; Pek L. Khong, FRCR ; Moira Chan-Yeung, MD ; James C. M. Ho, MD, FRCP ; Philip K. S. Chan ; Jeriel C. K. Lee ; Wah K. Lam, MD, FRCP ; Kenneth W. T. Tsang, MD, FRCP

PURPOSE: To evaluate clinical relevance of high-resolution computed tomographic (CT) findings in patients with bronchiectasis by using a quantitative high-resolution CT protocol to assess extent of bronchiectasis, severity of bronchial wall thickening, and presence of small-airway abnormalities and mosaic pattern.

MATERIALS AND METHODS: Sixty Chinese patients with steady-state bronchiectasis underwent thoracic high-resolution CT and lung function tests. Exacerbation frequency per year and 24-hour sputum volume were determined. Extent of bronchiectasis, severity of bronchial wall thickening, and presence of small-airway abnormalities and mosaic attenuation were evaluated in each lobe, including the lingula. Differences between sex and smoking status with respect to high-resolution CT, lung function, and clinical parameters were tested with either the independent sample t test or the Mann-Whitney test. Spearman rank correlation was used to evaluate associations between clinical, lung function, and high-resolution CT scores. Multiple regression analyses were performed to determine which high-resolution CT parameters would best predict lung function and clinical parameters, adjusted for smoking.

RESULTS: Exacerbation frequency was associated with bronchial wall thickening (r = 0.32, P = .03); 24-hour sputum volume with bronchial wall thickening and small-airway abnormalities (r = 0.30 and 0.39, respectively; P < .05); and forced expiratory volume in 1 second (FEV1), ratio of FEV1 to forced vital capacity (FVC), and midexpiratory phase of forced expiratory flow (FEF25%-75%) (r = −0.33, −0.29, and −0.32, respectively; P < .05). Extent of bronchiectasis, bronchial wall thickening, and mosaic attenuation, respectively, were related to FEV1 (r = −0.43 to −0.60, P < .001), FEF25%-75% (r = −0.38 to −0.57, P < .001), FVC (r = −0.36 to −0.46, P < .01), and FEV1/FVC ratio (r = −0.31 to −0.49, P < .01). After multiple regression analysis, bronchial wall thickening remained a significant determinant of airflow obstruction, whereas small-airway abnormalities remained associated with 24-hour sputum volume. Women had milder disease than men but showed more high-resolution CT functional correlations.

CONCLUSION: Findings of this study establish a link between morphologic high-resolution CT parameters and clinical activity and emphasize the role of bronchial wall thickening in patients with bronchiectasis.

Related Content

Want to get started?

We would love to talk with you.